Key features and details
- Mouse monoclonal [B017] to Influenza B Virus Nucleoprotein
- Suitable for: ELISA, WB, ICC/IF
- Isotype: IgG2b
Product nameAnti-Influenza B Virus Nucleoprotein antibody [B017]
See all Influenza B Virus Nucleoprotein primary antibodies
DescriptionMouse monoclonal [B017] to Influenza B Virus Nucleoprotein
Tested applicationsSuitable for: ELISA, WB, ICC/IFmore details
Species reactivityReacts with: Other species
Influenza B/Lee/40 and B/Singapore/-222/79 viruses.
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferpH: 7.50
Preservative: 0.09% Sodium azide
Concentration information loading...
PurityProtein G purified
Purification notes>95% pure (SDS-PAGE). Protein G Affinity chromatography.
Our Abpromise guarantee covers the use of ab20711 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ELISA||Use at an assay dependent dilution.|
|WB||Use at an assay dependent dilution.|
|ICC/IF||Use at an assay dependent dilution.|
RelevanceInfluenza virus B is a genus in the virus family Orthomyxoviridae. A limited host range means that Influenza virus B pandemics are rare. The nucleoprotein protects the negative strand viral RNA from nucleases by encapsidating it. encapsidated genomic RNA is termed the ribonucleoprotein (RNP) and serves as template for transcription and replication.
- Influenza B Virus NP antibody
- NP antibody
- Nucleocapsid protein antibody
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab20711 has been referenced in 8 publications.
- Staller E et al. ANP32 Proteins Are Essential for Influenza Virus Replication in Human Cells. J Virol 93:N/A (2019). PubMed: 31217244
- Schmidt N et al. An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity. Proc Natl Acad Sci U S A 116:17399-17408 (2019). PubMed: 31391303
- Nogales A et al. Replication-competent fluorescent-expressing influenza B virus. Virus Res 213:69-81 (2016). PubMed: 26590325
- Ran Z et al. Domestic pigs are susceptible to infection with influenza B viruses. J Virol 89:4818-26 (2015). PubMed: 25673727
- Krammer F et al. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. J Virol 88:3432-42 (2014). PubMed: 24403585
- Baker SF et al. Influenza A and B virus intertypic reassortment through compatible viral packaging signals. J Virol 88:10778-91 (2014). PubMed: 25008914
- Dauber B et al. Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR. PLoS Pathog 5:e1000473 (2009). ICC/IF . PubMed: 19521506
- Hai R et al. Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol 82:10580-90 (2008). ICC/IF . PubMed: 18768976